Clinical Oncology Next-Generation Sequencing Market Overview:
The Clinical Oncology Next-Generation Sequencing (NGS) Market, valued at USD 9.49 billion in 2023, is anticipated to witness remarkable growth, with revenues projected to surge at a CAGR of 20.7% from 2024 to 2030, reaching nearly USD 35.42 billion by 2030. This growth is primarily driven by advancements in technology, increasing cancer prevalence globally, and the growing demand for personalized medicine.
Market Dynamics:
Rising global cancer burden boosts demand for precise genomic analysis, propelling clinical oncology next-generation sequencing market growth.
Continuous improvements in NGS technology are boosting the Clinical Oncology Next-Generation Sequencing Market. For example, Illumina's NovaSeq platform will revolutionise cancer genome analysis by increasing sequencing speed and accuracy. This innovation propels market expansion by allowing for speedy and cost-effective genomic profiling in oncology research and clinical applications. The rising worldwide cancer burden, particularly in emerging countries, increases the need for accurate genomic analysis afforded by NGS. Thermo Fisher's Oncomine tests, which provide full molecular profile, address this requirement by facilitating targeted therapy selection and monitoring, hence accelerating market expansion amid escalating cancer incidence estimates.
Clinical Oncology Next-Generation Sequencing Market Scope and Research Methodology
The purpose of this report is to evaluate and forecast the size of the Clinical Oncology Next-Generation Sequencing market. It provides strategic profiles of key market participants, providing a clear picture of the competitive landscape in the worldwide Clinical Oncology Next-Generation Sequencing market. This covers a thorough examination of current developments such as new product introductions, acquisitions, mergers, joint ventures, brand activities, and important players in the Clinical Oncology Next-Generation Sequencing sector. The research provides insights into industry trends, dynamics, and potentials, helping professionals stay up to date on the current trends and sector performance. This information helps project increase and fall in Clinical Oncology Next-Generation Sequencing market share during the predicted period.
A thorough grasp of the Clinical Oncology Next-Generation Sequencing industry was gained through a combination of primary and secondary research techniques. To achieve reliable results, a variety of approaches were used, including PESTLE, PORTER, and SWOT analysis. SWOT analysis was used to identify the strengths, weaknesses, opportunities, and problems for important companies in the Clinical Oncology Next-Generation Sequencing industry. Furthermore, the application of PORTER and PESTLE analysis enabled an understanding of the microeconomic and macroeconomic aspects driving the Clinical Oncology Next-Generation Sequencing industry.
Clinical Oncology Next-Generation Sequencing Market Segmentation:
by Technology
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing
Others
by Workflow
Pre-Sequencing
Sequencing
Data Analysis
by Application
Screening
Diagnostics
by End-User
Hospitals
Clinics
Laboratories
Based on technology, Whole Genome Sequencing dominated the Clinical Oncology Next-Generation Sequencing Market in 2023. It provides a comprehensive view of an individual's entire genome, allowing for the identification of novel mutations and complex structural variations, but its adoption is hampered by high costs and extensive data analysis. Whole Exome Sequencing (WES) focuses on sequencing the genome's protein-coding regions, providing a balance of cost-effectiveness and extensive genomic coverage, making it ideal for finding cancer-related coding mutations. Targeted Sequencing, on the other hand, selectively reads specific regions of interest, resulting in excellent sensitivity and cost efficiency, especially when discovering known cancer-associated mutations. Other developing technologies, like as RNA sequencing or single-cell sequencing, provide additional insights into tumour biology and heterogeneity
Instant Access to Your Exclusive Sample Copy: https://www.maximizemarketresearch.com/request-sample/100383
Clinical Oncology Next-Generation Sequencing Market Key Players:
Major Contributors in the Clinical Oncology Next-Generation Sequencing Industry in North America:
1. Illumina, Inc.., San Diego, California, USA
2. Thermo Fisher Scientific, Inc., Waltham, Massachusetts, USA
3. Guardant Health, Inc., Redwood City, California, USA
4. PPacific Bioscience of California, Inc., Menlo Park, California, USA
5. Agilent Technologies, Inc., Santa Clara, California, USA
Leading players in the Europe Clinical Oncology Next-Generation Sequencing Market:
1. Qiagen N.V., Venlo, Netherlands
2. Roche Holdings AG (including Foundation Medicine), Basel, Switzerland
3. Oxford Nanopore Technologies Ltd., Oxford, United Kingdom
4. Genewiz Germany GmbH, Leipzig, Germany
5. Sophia Genetics SA, Saint-Sulpice, Switzerland
Key players driving the Asia-Pacific Clinical Oncology Next-Generation Sequencing Market:
1. Novogene Corporation, Beijing, China
2. BGI Group, Shenzhen, China
3. Takara Bio Inc., Kusatsu, Japan
4. MedGenome Labs Pvt. Ltd., Bengaluru, India
Regional Analysis:
North America dominates the clinical oncology next-generation sequencing market.
Several significant variables contribute to North America's dominance in the Clinical Oncology Next-Generation Sequencing (NGS) market. The region's dominance is highlighted by regulatory measures in the United States focused at improving cancer screening diagnosis, including as the National Cancer Institute's Cancer Genome Atlas programme, which has performed NGS on over 20,000 cancer samples from diverse types of the disease. The regulatory emphasis on early detection and diagnosis increases demand for clinical oncology NGS technologies. Furthermore, the region is witnessing an increase in the usage of sequencing platforms for clinical diagnosis, aided by lower installation costs.
Key Questions Addressed in This Report:
How has the Clinical Oncology Next-Generation Sequencing market performed so far and how will it perform in the coming years?
What is the market segmentation of the global Clinical Oncology Next-Generation Sequencing market?
What is the regional breakup of the global Clinical Oncology Next-Generation Sequencing market?
What are the price trends of various feedstocks in the Clinical Oncology Next-Generation Sequencing industry?
What is the structure of the Clinical Oncology Next-Generation Sequencing industry and who are the key players?
What are the various unit operations involved in a Clinical Oncology Next-Generation Sequencing processing plant?
What is the total size of land required for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What is the layout of a Clinical Oncology Next-Generation Sequencing processing plant?
What are the machinery requirements for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the raw material requirements for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the packaging requirements for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the transportation requirements for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the utility requirements for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the human resource requirements for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the infrastructure costs for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the capital costs for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the operating costs for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What should be the pricing mechanism of the final product?
What will be the income and expenditures for a Clinical Oncology Next-Generation Sequencing processing plant?
What is the time required to break even?
What are the profit projections for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the key success and risk factors in the Clinical Oncology Next-Generation Sequencing industry?
What are the key regulatory procedures and requirements for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
What are the key certifications required for setting up a Clinical Oncology Next-Generation Sequencing processing plant?
Kindly Click Here for More Information About This Study: https://www.maximizemarketresearch.com/request-sample/100383
Key Offerings:
- A detailed Analysis of the Market Overview
- Market Share, Size & Forecast by Revenue | 2024−2030
- Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
- Market Segmentation – A detailed analysis by Route of administration, Application, Facility of use and Region and Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
Top Related Reports:
Global Network Security Policy Management Market https://www.maximizemarketresearch.com/market-report/global-network-security-policy-management-market/20725/
Optometry/Eye Exam Equipment Market https://www.maximizemarketresearch.com/market-report/optometry-eye-exam-equipment-market/1439/
Comments